NEW YORK, July 30 – MDS Proteomics of Toronto unveiled Monday a new method designed to directly identify known and unknown proteins based on mass spectrometry data.

Using advanced algorithms developed by Matthias Mann, chief proteomics officer of MDS Proteomics, the PepSea technology is designed to identify any protein and to locate and identify the genes the encode the proteins.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.